Seagen Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Seagen Inc inventory turnover ratio, the Seagen Inc 's ability to sell and replace its inventory in the third quarter 2023, sequentially increased to 1.18 in the third quarter 2023, SGEN's markets remain strong, its supply chain continue to be in a grate shape.Average inventory processing period, for the Seagen Inc in Sep 30 2023 quarter, has decreased to 309 days, compare to 315 days, in the Jun 30 2023 quarter.

Within Healthcare sector 329 other companies have achieved higher inventory turnover ratio. While Inventory turnover ratio total ranking has improved so far during the III Quarter 2023, to 354, from total ranking in the second quarter 2023 at 831.

SGEN Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Seagen Inc Market Share?

What is Inventory Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Inventory Turnover▼

None ▼

Inventory Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

SGEN Inventory Turnover Ratio	(Sep 30 2023) III. Quarter	(Jun 30 2023) II. Quarter	(Mar 31 2023) I. Quarter	(Dec 31 2022) IV. Quarter	(Sep 30 2022) III. Quarter
Y / Y Inventory Growth	45.54 %	52.45 %	73.24 %	112.9 %	101.22 %
Y / Y Cost of Sales Growth	52.84 %	70.36 %	27.56 %	24.82 %	30.82 %
Inventory Turnover Ratio (TTM)	1.18	1.16	1.09	1.18	1.34
SGEN's Total Ranking	# 354	# 831	# 722	# 1848	# 1529
Average inventory processing period	310	315	334	309	273
Seq. Inventory Growth	9.11 %	1.92 %	11.82 %	17.05 %	14.28 %
Seq. Cost of Sales Growth	-8.57 %	61.71 %	3.3 %	0.08 %	1.91 %

Inventory Turnover Ratio Company Ranking
Within:	No.
Biotechnology & Pharmaceuticals Industry	# 23
Healthcare Sector	# 330
Overall Market	# 354

Inventory Turnover Ratio Statistics
High	Average	Low
2.25	0.94	0.41
(Dec 31 2020)		(Sep 30 2016)

SGEN Company Profile >> Back to SGEN Efficiency Comparisons >> Compare SGEN Inventory Turnover Ratio to its Competitors

Financial Statements
Seagen Inc 's Inventories	$ 531 Millions	Visit SGEN's Balance sheet
Seagen Inc 's Cost of Revenues TTM	$ 566 Millions	Visit SGEN's Income Statement
What are SGEN's Sales?		Visit SGEN's Sales by Segment

Other Inventory Turnover Ratios
Seagen Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Biotechnology & Pharmaceuticals Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
SGEN's Inventory Turnover Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for SGEN's Competitors
Inventory Turnover Ratio for SGEN's Suppliers
Inventory Turnover Ratio for SGEN's Customers

You may also want to know
SGEN's Sales Growth Rates	SGEN's Pe Price to earnings ratio	SGEN's Receivables Turnover Ratio	SGEN's Stock Quote
SGEN's Net Income Growth Rates	SGEN's Ps Price to Sales ratio	SGEN's Sales per Employee	SGEN's Asset Turnover Ratio
SGEN's Net Margin	SGEN's Pb Price to Book ratio	SGEN's Financial Strength Ratios	SGEN's Dividend Payout Ratio

Companies with similar Inventory Turnover Ratio for the quarter ending Sep 30 2023, within Healthcare Sector	Inventory Turnover Ratio	Cost of revenues at quarter ending Sep 30 2023	Inventories at quarter ending Sep 30 2023
Quidelortho Corp	2.90	$ 1,557.599 Millions	$ 537 Millions
Aytu Biopharma Inc	2.90	$ 37.377 Millions	$ 13 Millions
Mettler toledo International Inc	2.90	$ 1,188.193 Millions	$ 410 Millions
Avid Bioservices Inc	2.89	$ 121.815 Millions	$ 42 Millions
Illumina Inc	2.89	$ 1,722.000 Millions	$ 597 Millions
Elutia Inc	2.86	$ 26.390 Millions	$ 9 Millions
Dentsply Sirona Inc	2.86	$ 1,855.000 Millions	$ 649 Millions
Telesis Bio Inc	2.86	$ 9.023 Millions	$ 3 Millions
Tandem Diabetes Care Inc	2.86	$ 381.324 Millions	$ 133 Millions
Angiodynamics Inc	2.83	$ 162.768 Millions	$ 58 Millions
Amneal Pharmaceuticals Inc	2.81	$ 1,533.561 Millions	$ 547 Millions
Evolus Inc	2.79	$ 55.659 Millions	$ 20 Millions
Pfizer Inc	2.77	$ 27,041.000 Millions	$ 9,759 Millions
Iridex Corp	2.74	$ 29.531 Millions	$ 11 Millions
Msa Safety Inc	2.74	$ 924.000 Millions	$ 337 Millions
Waters Corporation	2.73	$ 1,225.053 Millions	$ 448 Millions
Abbott Laboratories	2.73	$ 18,012.000 Millions	$ 6,592 Millions
Merck and Co Inc	2.70	$ 16,095.000 Millions	$ 5,959 Millions
Hologic Inc	2.69	$ 1,788.500 Millions	$ 666 Millions
Electromedical Technologies Inc	2.68	$ 0.313 Millions	$ 0 Millions
Skinhealth Systems Inc	2.67	$ 280.806 Millions	$ 105 Millions
Zynex inc	2.67	$ 37.482 Millions	$ 14 Millions
Axsome Therapeutics Inc	2.66	$ 20.978 Millions	$ 8 Millions
Quanterix Corporation	2.66	$ 48.002 Millions	$ 18 Millions
Logicmark Inc	2.62	$ 3.271 Millions	$ 1 Millions
International Stem Cell Corporation	2.61	$ 3.454 Millions	$ 1 Millions
Amphastar Pharmaceuticals Inc	2.61	$ 275.164 Millions	$ 105 Millions
Perrigo Company Plc	2.60	$ 3,018.000 Millions	$ 1,163 Millions
Lifevantage Corp	2.58	$ 43.058 Millions	$ 17 Millions
Jin Medical International Ltd	2.58	$ 13.037 Millions	$ 5 Millions

Date modified: 2026-08-29T17:24:33+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.